Announcements Trials
Browse Landscape

Phase

Phase 2 30Phase 3 3Phase NA 2Phase 4 2Phase 2/3 2Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Unknown 14Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Small Cell Lung Carcinoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 104Standard of Care 79Exercise 67Radiotherapy 53Radiosurgery 48Specimen Handling 45Magnetic Resonance Spectroscopy 45Surveys and Questionnaires 44Interviews as Topic 44Practice Guidelines as Topic 43Educational Status 43Methods 41Drug Therapy 35Early Intervention, Educational 30Surgical Procedures, Operative 29Palliative Care 25Control Groups 25Biopsy 24Patient Navigation 18venetoclax 17Cisplatin 17Therapeutics 16Resistance Training 16Proton Therapy 15Magnetic Resonance Imaging 15Behavior Therapy 15Neoadjuvant Therapy 13Cognitive Behavioral Therapy 13Acupuncture Therapy 13Nutritional Status 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Recruiting × anlotinib × Clear all
NCT06258642 2025-08-20

Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC

Fudan University

Phase NA Recruiting
39 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT06188650 2024-01-03

The Efficacy and Safety of Drug Loaded Microsphere Bronchial Artery Chemoembolization (DEB-BACE) Combined With Anlotinib and Adebelimumab in the Third Line Treatment of Advanced NSCLC: a Prospective, Single Arm, Single Center, Exploratory Clinical Study

Ningbo Medical Center Lihuili Hospital

Phase NA Recruiting
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡